PRVA

SEC source: 0001759655-25-000116 · wk-form4_1765921039.xml · derivative · entry 7

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,866

Underlying: Common Stock, par value $0.01 per share · 7,967 shares

Expires 2030-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable.

SEC source: 0001759655-25-000116 · wk-form4_1765921039.xml · derivative · entry 6

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,501

Underlying: Common Stock, par value $0.01 per share · 3,430 shares

Expires 2029-12-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable.

SEC source: 0001759655-25-000116 · wk-form4_1765921039.xml · derivative · entry 5

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,452

Underlying: Common Stock, par value $0.01 per share · 4,792 shares

Expires 2029-03-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable.

SEC source: 0001759655-25-000116 · wk-form4_1765921039.xml · derivative · entry 4

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,820

Underlying: Common Stock, par value $0.01 per share · 7,698 shares

Expires 2028-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable.

SEC source: 0001759655-25-000116 · wk-form4_1765921039.xml · nonDerivative · entry 2

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 172,909

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.16 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-25-000116 · wk-form4_1765921039.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 196,796

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

SEC source: 0001759655-25-000087 · wk-form4_1752782665.xml · nonDerivative · entry 1

BERBERIAN LANCE · CIK 0001102900 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,668

F1 · shares: Represents restricted stock units granted the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2026 Annual Meeting of Stockholders.

SEC source: 0001759655-25-000071 · wk-form4_1748033919.xml · nonDerivative · entry 1

Ryu Jaewon · CIK 0001869233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,647

F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-25-000072 · wk-form4_1748034008.xml · nonDerivative · entry 1

Maryland Patricia Anne · CIK 0001798468 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,312

F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-25-000070 · wk-form4_1748033859.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,188

F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-25-000075 · wk-form4_1748034223.xml · nonDerivative · entry 1

WICHMANN DAVID S · CIK 0001268489 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,709

F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-25-000074 · wk-form4_1748034128.xml · nonDerivative · entry 1

COCOZZA NANCY G · CIK 0001232953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,351

F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-25-000076 · wk-form4_1748034271.xml · nonDerivative · entry 1

KING DAVID P · CIK 0001275654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,312

F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-25-000077 · wk-form4_1748034690.xml · nonDerivative · entry 1

McCarthy Thomas A · CIK 0001500886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,520

F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-25-000073 · wk-form4_1748034064.xml · nonDerivative · entry 1

Kimmet Pamela O · CIK 0001589981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,709

F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-25-000054 · wk-form4_1747260346.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 407,234

F2 · shares: This transaction occurred pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.23 to $24.91 per share. The Reporting Person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-25-000054 · wk-form4_1747260346.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 423,143

F1 · shares: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to a sell to cover transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000053 · wk-form4_1747260303.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,909

F1 · shares: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to a sell to cover transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000041 · wk-form4_1746219501.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 436,916

F2 · shares: This transaction occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.87 to $23.43 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-25-000042 · wk-form4_1746219593.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,792

F1 · shares: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000043 · wk-form4_1746219670.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,231

F1 · shares: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000041 · wk-form4_1746219501.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,281

F1 · shares: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000037 · wk-form4_1743713778.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,676

F1 · shares: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to a "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000035 · wk-form4_1741983038.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 469,381

F1 · kind: This transaction occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person.

SEC source: 0001759655-25-000030 · wk-form4_1741813581.xml · nonDerivative · entry 2

Fargis Edward C · CIK 0002009323 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,054

F1 · kind: The sales reported in this Form 4 represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000032 · wk-form4_1741813771.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479,895

F1 · kind: The sales reported in this Form 4 represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000031 · wk-form4_1741813668.xml · nonDerivative · entry 2

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,306

F1 · kind: The sales reported in this Form 4 represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000030 · wk-form4_1741813581.xml · nonDerivative · entry 1

Fargis Edward C · CIK 0002009323 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,492

F1 · kind: The sales reported in this Form 4 represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000032 · wk-form4_1741813771.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 489,189

F1 · kind: The sales reported in this Form 4 represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000031 · wk-form4_1741813668.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,178

F1 · kind: The sales reported in this Form 4 represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-25-000026 · wk-form4_1741354652.xml · nonDerivative · entry 1

Fargis Edward C · CIK 0002009323 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,021

F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.

SEC source: 0001759655-25-000025 · wk-form4_1741354609.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,157

F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.

SEC source: 0001759655-25-000024 · wk-form4_1741354552.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 498,829

F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.

SEC source: 0001759655-25-000006 · wk-form4_1739999824.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,727

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.40 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · derivative · entry 13

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.01 par value per share · 16,144 shares

Expires 2035-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · derivative · entry 12

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.01 par value per share · 52,546 shares

Expires 2034-12-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · derivative · entry 11

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.01 par value per share · 48,645 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · nonDerivative · entry 7

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 365,106

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · nonDerivative · entry 6

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 348,962

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · nonDerivative · entry 5

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 296,416

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · derivative · entry 10

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,144

Underlying: Common Stock, $0.01 par value per share · 18,595 shares

Expires 2035-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · derivative · entry 9

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,546

Underlying: Common Stock, $0.01 par value per share · 60,520 shares

Expires 2034-12-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · derivative · entry 8

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,645

Underlying: Common Stock, $0.01 par value per share · 56,027 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · nonDerivative · entry 4

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 247,771

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.37 to $18.73 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · nonDerivative · entry 3

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 382,913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 364,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

SEC source: 0001759655-24-000125 · wk-form4_1726176646.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 303,798

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions occurred pursuant to a 10b5-1 trading plan previously adopted by the reporting person. The sale was made to cover the payment of the exercise price and tax obligations related to the exercise of stock options, with the balance of the shares acquired upon exercise continuing to be held by the reporting person.

SEC source: 0001759655-24-000123 · wk-form4_1724445147.xml · derivative · entry 7

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 89,319

Underlying: Common Stock, par value $0.01 per share · 89,319 shares

Expires 2031-04-29

F1 · kind: On August 21, 2024, the Reporting Person's spouse transferred her 49% interest in Emerald Family, LLC, which, immediately preceding the transfer, held 24,485 shares of Common Stock par value $0.01 of the Issuer, 315,666 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $2.00 and 182,283 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $23.00, to a family trust ("Trust"). The Reporting Person and his children are the beneficiaries of the Trust. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

F2 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000123 · wk-form4_1724445147.xml · derivative · entry 6

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Emerald Family, LLC

Disclosed balance after: 92,964

Underlying: Common Stock, par value $0.01 per share · 89,319 shares

Expires 2031-04-29

F1 · kind: On August 21, 2024, the Reporting Person's spouse transferred her 49% interest in Emerald Family, LLC, which, immediately preceding the transfer, held 24,485 shares of Common Stock par value $0.01 of the Issuer, 315,666 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $2.00 and 182,283 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $23.00, to a family trust ("Trust"). The Reporting Person and his children are the beneficiaries of the Trust. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

F2 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000123 · wk-form4_1724445147.xml · derivative · entry 5

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 154,676

Underlying: Common Stock, par value $0.01 per share · 154,676 shares

Expires 2033-08-27

F1 · kind: On August 21, 2024, the Reporting Person's spouse transferred her 49% interest in Emerald Family, LLC, which, immediately preceding the transfer, held 24,485 shares of Common Stock par value $0.01 of the Issuer, 315,666 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $2.00 and 182,283 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $23.00, to a family trust ("Trust"). The Reporting Person and his children are the beneficiaries of the Trust. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

F2 · derivative.exercise_date: All stock options are fully vested and exercisable.